Answers are grounded in this paper and cite their sources.
This framework integrates simulated hyperspectral imaging and hybrid machine learning to improve skin cancer diagnosis, implying enhanced clinical outcomes.
Skin cancer diagnosis requires accurate lesion classification and reliable stage estimation to enable timely clinical intervention. This study proposes a stage-aware multimodal framework integrating simulated hyperspectral reconstruction with hybrid deep learning and machine learning techniques. Initially, RGB dermoscopic images are preprocessed and enhanced, followed by feature-level class balancing using SMOTE. Principal Component Analysis (PCA) is employed to generate simulated hyperspectral representations, enriching spectral information beyond conventional RGB imaging. Deep semantic features are extracted using a Convolutional Neural Network (CNN), while clinically significant handcrafted features—including tumor diameter, asymmetry index, circularity, and entropy—are computed to capture morphological characteristics. These features are fused and classified using a Support Vector Machine (SVM) for tumor detection, followed by Artificial Neural Network (ANN)-based stage estimation. Experimental results demonstrate that the proposed hybrid framework achieves superior performance, with improved classification accuracy, enhanced robustness under class imbalance, and better generalization compared to single-model approaches. Furthermore, a stage-aware clinical recommendation module provides interpretable and actionable diagnostic insights, enhancing real-world applicability. The proposed system offers a cost-effective and explainable solution for intelligent skin cancer diagnosis.
No takes yet. Share an insight, caveat, or question.
K et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: